Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (KCT0011491) titled 'CGRealloputty Injection for Improving Rippling After Breast Reconstruction' on Jan. 20.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Single Group, Blinding/Masking : Open, Allocation : Not Applicable
Primary Sponsor: Yonsei University Health System, Severance Hospital
Condition:
Diseases of the skin and subcutaneous tissue
Intervention:
Others(biological product) : Before use of the investigational human tissue product (CGRealloputty), the expiration date indicated on the product label and any signs of package damage shall be checked. After identifying the targ...